Stock Price Quote

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01031Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE1208.007.9 (+0.66 %)
PREV CLOSE ( ) 1200.10
OPEN PRICE ( ) 1182.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 199793
TODAY'S LOW / HIGH ( )1182.05 1208.00
52 WK LOW / HIGH ( )1080.05 1414.4
NSE1203.00-3.2 (-0.27 %)
PREV CLOSE( ) 1206.20
OPEN PRICE ( ) 1198.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1203.00 (130)
VOLUME 3075974
TODAY'S LOW / HIGH( ) 1189.00 1206.60
52 WK LOW / HIGH ( )1101 1414.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email mail@drreddys.com / shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, New York

NEWS

18Sep Clarification-Disclosure Under Regula
Clarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations..
17Sep Clarification sought from Dr Reddys L
The Exchange has sought clarification from Dr Reddys Laboratories Ltd on..
16Sep Dr. Reddy's Laboratories launches NIVO
Dr. Reddy's Laboratories has launched ‘NIVORZ’ (Nivolumab Biosimilar) in..
20Aug Dr Reddys Laboratories informs about n
Dr Reddys Laboratories has enclosed the copies of newspaper publication..
17Aug USFDA completes GMP inspection at Dr.
United States Food & Drug Administration (USFDA) has completed a GMP..

Financials

in Millions
QTR Jun 26 ANNUAL 26
Net Profit404732197
Gross Profit 4970 42513
Operating Profit 887856070
Net Sales 51366205328

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  21857.25 (1.68%)
M.Cap ( in Cr)28042.61
Haleos Labs (BSE)
peergroup  1549.00 (5.87%)
M.Cap ( in Cr)468.31
NGL Fine-Chem (BSE)
peergroup  3009.65 (2.88%)
M.Cap ( in Cr)1859.37
Kwality Pharma (BSE)
peergroup  3641.50 (1.94%)
M.Cap ( in Cr)3778.49
Gland Pharma (BSE)
peergroup  2913.00 (1.37%)
M.Cap ( in Cr)48067.66

Shareholding Pattern

NON-INSTITUTION 9.55%
PROMOTERS 26.64%
FI/BANKS/INSURANCE 15.33%
MUTUAL FUNDS/UTI 13.16%
GOVERNMENT 0%
FII 0%

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 1208. Its current market capitalisation stands at Rs 100829.38 Cr. In the latest quarter, company has reported Gross Sales of Rs. 205328 Cr and Total Income of Rs.222224 Cr. The company's management includes Srikanth Velamakanni, Alpna Seth, Shikha Sharma, Sanjiv Mehta, Penny Wan, K P Krishnan, Claudio Albrecht, Arun Kumar, Leo Puri, GV Prasad, K Satish Reddy, K Randhir Singh.

It is listed on the BSE with a BSE Code of 500124 , NSE with an NSE Symbol of DRREDDY and ISIN of INE089A01031. It's Registered office is at 8-2-337,Road No. 3,Banjara HillsHyderabad-500034, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are A Rama Chandra Rao & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)